News 44th Annual J.P. Morgan Healthcare Conference Presentation Writer : Alteogen Date : 2026.01.16 PREV Alteogen CEO Interview Featured in Scrip Citeline NEXT Alteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of a Subcutaneous Formulation of Dostarlimab Enabled by Hybrozyme™ Technology List
